Indexed with PubMed and Science Citation Index (E) 
Users online: 2917 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
    Next article
    Previous article
    Table of Contents

    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded2    
    Comments [Add]    

Recommend this journal


Year : 1985  |  Volume : 51  |  Issue : 4  |  Page : 198--201

Effect of Prothionamide on the Infectivity of Lepromatous Leprosy

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 28164960

Rights and PermissionsRights and Permissions

To study the effect of prothionamide. on the infectivity of untreated lepromatous patients 20 cases were randomly given either 250 mg or 500 mg prothionamide monotherapy daily for 2 months. All patients tolerated the drug well. Clinical improvement with healing of mucosal ulcers was seen in 13 of the 16 cases. Nasal smears become negative in all the cases within 2 months. Mouse footpad inoculation done from biopsy specimens/skin scrape suspension- s became non infective to mice in all the cases within the trial period. There was a substantial reduction in ,the MI and histopathology showed complete fragmentation of the bacilli with a significant increase in the lymphocyte content. The -findings suggest a rapid bactericidal effect and a similar, use fullness on both the doses of the drug for the treatment of multibacillary leprosy.


Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow